Home » Newsletters » BioWorld

BioWorld

April 12, 1994

View Archived Issues

BRITISH FUND TO BUILD BIOTECH INVESTMENTS

DEPOTECH COMPLETES FINANCING, COLLABORATION WITH CHIRON

ABBOTT ENTERS AGREEMENTS WITH ROCHE, PERKIN-ELMER

APPOINTMENTS AND ADVANCEMENTS

CLARIFICATIONS

SCICLONE GETS RIGHT TO MANUFACTURE HEPATITIS B DRUG

TELOMERASE PRESENT IN CANCER CELLS

NEW JERSEY WANTS TO WOO BIOTECHNOLOGY COMPANIES

PULMOZYME ENTERS IRELAND

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...